Article

2011 ACC VIDEO: Cardiovascular Screening in HIV

Dr. Alexander Goehler explains that due an increase in longevity of HIV-infected patients, cardiovascular issues are becoming more prevalent.

Dr. Alexander Goehler discusses his poster, "Clinical Benefit and Cost Effectiveness of Cardiovascular Disease Screening in HIV Infected Patients," at ACC's 60th Annual Scientific Sessions. Goehler explains that the reason for conducting this study is due to an increased longevity of HIV-infected patients, which has led to an increase in developing cardiovascular issues in these patients.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.